2Appel GB, Cohen DJ, Pirani CL, et al. Long-term follow-up of pa- tients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med, 1987,83:877-885.
4Markowitz GS, D'Agati VD. The ISN/RPS 2003 classification of lupus nephritis: An assessment at 3 years. Kidney Int, 2007,71 : 491-495.
5Sprenger KB, Huber K,Kratz W, et al. Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher, 1987,3:185-190.
6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAh A disease activity index for lupus patients. Arthritis Rheum, 1992,35 : 630-640.
7Bao H,Liu ZH,Xie HL,et al. Successful treatment of class V + IV lupus nephritis with multitarget therapy. J Am Soc Nephrol, 2008,19:2001-2010.
8Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trial of plas- mapheresis therapy in severe lupus nephritis. The Lupus Nephri- tis Collaborative Study Group. N Engl J Med, 1992, 326: 1373- 1379.
9Clark WF, Rock GA, Buskard N, et al. Therapeutic plasma ex- change: An update from the Canadian Apheresis Group. Ann In- tern Med, 1999,131 :453-462.
